IL17A and Intervertebral disk degeneration: The nanocomposite hydrogel system shows promise for the minimally invasive and effective treatment of intervertebral disk degeneration by controlling anabolism and catabolism in the ECM and inhibiting the IL17 signaling pathway (M1‐related pathway) in vitro and in vivo.